KBC Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56K Buy
6,818
+1,764
+35% +$26.3K ﹤0.01% 1689
2026
Q2
$120K Hold
5,054
– – ﹤0.01% 1303
2026
Q1
$89K Hold
5,054
– – ﹤0.01% 1387
2025
Q4
$100K Hold
5,054
– – ﹤0.01% 1273
2025
Q3
$88K Buy
5,054
+1,916
+61% +$28.4K ﹤0.01% 1336
2025
Q2
$44K Buy
+3,138
New +$50.5K ﹤0.01% 1645

Other funds holding ALHC

KBC Group's ALHC Position: Q3 2026 in Review

KBC Group increased its Alignment Healthcare (ALHC) stake by 35% in Q3 2026, buying an estimated $26.3K and bringing the position to 6,818 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

KBC Group first reported a position in ALHC in Q2 2025 and has held it in 6 quarters since. The position peaked at $120K in Q2 2026. 188 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • KBC Group held 6,818 shares of Alignment Healthcare worth $56K as of Q3 2026.
  • KBC Group bought 1,764 Alignment Healthcare shares in Q3 2026, an estimated $26.3K.
  • Alignment Healthcare made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1689 holding.
  • KBC Group first reported a position in Alignment Healthcare in Q2 2025 and has held it in 6 quarters since.
  • KBC Group's Alignment Healthcare position peaked at $120K in Q2 2026.
  • 188 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.